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The paper entitled "Regulation of DARPP-32 dephosphorylation at PKA and Cdk5-sites by NMDA and AMPA receptors", authored by Nishi, A., Bibb, J.A., Matsuyama, S., Hamada, M., Higushi, H., Nairn, A.C. and Greengard. P., and published in the Journal of According to the authors of the paper, they investigated the effects of ionotropic glutamate NMDA and AMPA receptors on DARPP-32 phosphorylation in neostriatal slices and claimed to have shown that activation of NMDA and AMPA receptors caused the decrease of phosphorylations of threonone 34 and threonine 75 DARPP-32 mediated by Ca 2+ -dependent activation of calcineurin and protein phosphatase-2A respectively.
Various data were presented including Figure 1 which showed (i) Immunoblots of Phospho-Thr34 in neostriatal slices following no treatment, treatment with AMPA, treatment with NMDA plus MK801, and treatment with MK801 only (Figure 1a ), (ii)
Immunoblots of Phospho-Thr34 in neostriatal slices following no treatment, treatment with AMPA, treatment with NMDA plus CNQX, and treatment with CNQX alone (Figure 1b ), (iii) Immunoblots of Phospho-Thr75 in neostriatal slices following no treatment, treatment with AMPA, treatment with NMDA plus MK801, and treatment with MK801 only (Figure 1c ), (ii) Immunoblots of Phospho-Thr34 in neostriatal slices following no treatment, treatment with AMPA, treatment with NMDA plus CNQX, and treatment with CNQX alone (Figure 1d ). Figure 1 "treatment of slices with NMDA (100 µM) for 5 min decreased the level of phospho-Thr34 DARPP-32 to 26.4 ± 7.9% of control" (Fig. 1a) , (ii) "Pretreatment of slices with an NMDA receptor antagonist, MK801 (100 µM), for 10 min did not affect the basal level of phospho-Thr34 DARPP-32. How-ever, the effect of NMDA on DARPP-32 Thr34 phosphory-lation was abolished by MK801", (iii) Treatment of slices with AMPA (50 µM) for 5 min decreased the level of phospho-Thr34 DARPP-32 to 66.0 ± 7.6% of control ( Fig. 1b) , (iv) Pretreatment of slices with an AMPA receptor antagonist, CNQX (20 µM), for 10 min increased the basal level ofphospho-Thr34 DARPP-32, possibly by antagonizing the effects of endogenously released glutamate. The effect of AMPA on DARPP-32 Thr34 phosphorylation was antagon-ized by CNQX. How with the same Immunoblot (Figure 1(a) and Figure 1(b) , the authors were able to come up with different statistical analysis of 26.4 ± 7.9% of control for Figure 1(a) and 66.0 ± 7.6% of control for Fig. 1b is beyond normal scientific comprehension and in the realm of science fiction. 
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